openPR Logo
Press release

Hospital Acquired Pneumonia Drugs Market Report by Major Drugs and Vaccines Market Analysis 2020

02-06-2017 01:14 PM CET | Health & Medicine

Press release from: TMR - Research Reports

Hospital Acquired Pneumonia Drugs Market Report by Major Drugs

Hospital-acquired pneumonia also called as healthcare associated pneumonia or nosocomial pneumonia is acquired in hospital premises. Unlike community acquired pneumonia hospital acquired pneumonia is mainly caused due to multidrug resistant microorganisms. The report analyzes the market for late stage candidates for treatment of nosocomial pneumonia, and also provides a detailed review of drugs in early stages of clinical trials. The report studies and estimates market for six late stage along with an elucidation of ten early stage candidates for nosocomial pneumonia treatment.

PDF Containing the Upcoming Market Analysis of Hospital Acquired Pneumonia Drugs is available at: http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=1881

Phase III candidates include tedizolid phosphate, ceftolozane/tazobactam, ceftazidime/avibactam, amikacin inhale, plazomicin and synflorix vaccine. Market for each of the investigational drugs is estimated based on current anti-microbial efficiency, historic market trend and patents of drugs from similar class, manufacturing and marketing licenses, along with competition from commercialized and pipeline drugs. Hospital acquired pneumonia drugs market for phase III candidates has been estimated from the expected year of launch till 2020. The hospital acquired pneumonia drugs market report also gives a brief review of the various drugs commercially available for treating hospital acquired pneumonia. Historic market revenue of these drugs from 2011 to 2013 has also been included. Market forecast mainly rests on a detailed event impact analysis, which considers historic as well as anticipated events which impact the market in varying degrees.

Global market for hospital acquired pneumonia drugs is mainly driven by the increasing prevalence of nosocomial infections across the globe. To illustrate this fact, the report includes a statistical comparison of the prevalence of nosocomial infections in various developed and developing countries. Geographical trend of hospital acquired pneumonia drugs market, is explains with a brief regulatory approval process, along with expected time frame for drug launch in various countries. These trends have been explained for geographical regions including North America, Europe, Asia Pacific and Rest of the World.

To gain a complete market understanding, Porters Five Force’s analysis, and value chain analysis has also been included in the hospital acquired pneumonia drugs market report. The report also explains key market drivers, restraints, opportunities in the hospital acquired pneumonia drugs market. Diagnosis, treatment, and epidemiology of hospital acquired pneumonia gives a clinical overview of the disease and current modes of disease management. Relevant recommendations have been suggested for designing successful market strategies for competing in the market.

Hospital acquired pneumonia drugs market report also includes company profiles of key market players. These include Achaogen, Inc., Aridis Pharmaceuticals, AstraZeneca plc, Cubist Pharmaceuticals, Inc., Meiji Seika Pharma Co. Ltd., Merck & Co. Ltd., Sanofi, GlaxoSmithKline, Inc., and Valneva SE. All of these players are profiled considering company overview, financial overview, product portfolio, business strategies, and recent developments.

Read the Current Market Status of Hospital Acquired Pneumonia Drugs at: http://www.transparencymarketresearch.com/hospital-acquired-pneumonia-drugs.html

The research methodology was based on primary as well as secondary research. Interviews and discussions with a wide range of key industry participants and opinion leaders revealed real time market scenario. This primary research represented the bulk of the research efforts, which was further supplemented by extensive secondary research. A review of key players’ product literature, annual reports, and press releases supports the market forecast analysis. The 74 page report explains various market dynamics in 4 tables and 17 figures and charts.

Transparency Market Research (TMR) is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of Analysts, Researchers, and Consultants, use proprietary data sources and various tools and techniques to gather and analyze information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com/

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Hospital Acquired Pneumonia Drugs Market Report by Major Drugs and Vaccines Market Analysis 2020 here

News-ID: 429634 • Views:

More Releases from TMR - Research Reports

Pulmonary Drugs Market is Expected to Reach US$ 28,082.1 Million by the End of 2024
Pulmonary Drugs Market is Expected to Reach US$ 28,082.1 Million by the End of 2 …
According to the research report, the global pulmonary drugs market is expected to be worth US$ 28,082.1 mn by the end of 2024 as compared to US$ 48,039.7 mn in 2015. Analysts calculate that the global market will plummet at a CAGR of -6.3% during the forecast period of 2016 and 2024. The market will thrive as the demand for combination drugs is anticipated to remain on the rise during
North America Ventricular Assist Device Market is rising to a valuation of US$ 1.07 Billion by 2024
North America Ventricular Assist Device Market is rising to a valuation of US$ 1 …
According to TMR, the opportunity in the North America market for VADs, which stood at US$0.4 bn in 2015, is likely to expand at a healthy CAGR of 9.20% between 2016 and 2024 and increase to US$1.07 bn by the end of the forecast period. The destination therapy (DT) segment has been reporting a greater application of VADs than the other two indication segments. It is expected to remain the
Dental Membrane and Bone Graft Substitutes Market to rise to US$ 922.6 Million by 2024
Dental Membrane and Bone Graft Substitutes Market to rise to US$ 922.6 Million b …
Transparency Market Research notes that innovation and expansion into emerging regions have served these companies well in strengthening their hold in the dental membrane and bone graft substitutes market. For instance, Switzerland-based Geistlich Pharma AG - a global manufacturer and supplier of dental products and devices - expanded its operations in Sydney, Australia and New Delhi, India in 2016. The global dental membrane and bone graft substitutes market is expected to
Human Vaccines Market is Estimated to Reach US$ 72.5 Billion by 2024
Human Vaccines Market is Estimated to Reach US$ 72.5 Billion by 2024
The global human vaccines market was valued at US$28.3 bn in 2015 and is estimated to reach US$72.5 bn by 2024, registering an 11.2% CAGR during the forecast period. By age group, pediatric vaccines accounted for a 57.5% share in the global human vaccines market in 2015. Adult vaccines, on the other hand, are expected to expand at a 13.2% CAGR from 2016 to 2024. Based on product, the pneumococcal segment

All 5 Releases


More Releases for Hospital

Outbound Medical Tourism Services Market 2021-2027| Christus Muguerza Hospital, …
Outbound Medical Tourism Services refers to people traveling abroad to obtain medical treatment. An informative data report titled Outbound Medical Tourism Services Market was published by Reportsweb. It takes a closer look at the different aspects of the businesses, that are responsible for fuelling the growth of the companies. Additionally, it offers some significant factors, which are restraining the progress of the industries. To predict the turning point of the businesses,
Canada Hospital Supplies Market Report - Disposable Hospital Supplies, Hospital …
ReportsnReports added a new report on The Canada Hospital Supplies Market report that delivers the clean elaborated structure of the Report comprising each and every business-related information of the market at a global level. The in-depth study on the current state which focuses on the major drivers and restraints for the key players. Canada Hospital Supplies Market Industry research report provides granular analysis of the market share, segmentation, revenue forecasts,
Veterinary Orthopedic Treatment Market Key Players| Adobe Animal Hospital, Allan …
A Comprehensive research study conducted by KD Market Insights on " Veterinary Orthopedic Treatment Market by Procedure (Cruciate Ligament Tear, Patellar Luxation, Hip Dysplasia, Elbow Dysplasia, Bone Fracture, and Osteoarthritis Management), and Animal Type (Dog, Cat and Other Animal Types): Global Opportunity Analysis and Industry Forecast, 2017 - 2025" report offers extensive and highly detailed historical, current and future market trends in the global and regional/market. The Veterinary Orthopedic Treatment Market report includes market size,
Hospital Profitability Market SWOT Analysis of Key Players- Mayo Clinic Hospital …
HTF MI has added the report on Global Hospital Profitability Market for the forecast till 2025, the report comprises of the estimation of the Global Hospital Profitability Market. The following Industry is shown to progress with a noteworthy rise in the Compound Annual Growth Rate (CAGR) during the forecast period owing to various factors driving the market. Some of the key players mentioned in this research are "Mayo Clinic Hospital,
Medical Tourism Market Key Players- Bumrungrad International Hospital, Bangkok C …
As per the current market trends and the promising nature of the “Global Medical Tourism Market” market, it can be estimated that the future holds positive outcomes. In order to provide a deep insight about the concerned market, Market Research Reports Search Engine would be publishing a resourceful analysis that will enclose knowledge about the regional market size, revenue and opportunity status. Readers will be offered the privilege to decode
Hospital Profitability Market - Mayo Clinic Hospital, The Cleveland Clinic, The …
Global Hospital Profitability Market Size, Status and Forecast 2022 provides Market information about top Key Players, Countries, Type and Application. This Industry report also states Company Profile, sales, Hospital Profitability Market revenue and price, market share, market growth and gross margin by regions. Top Key Players: Mayo Clinic Hospital The Cleveland Clinic The Jhons Hopkins Hospital Massachusetts General Hospital Ronald Reagan UCLA Medical Center Peking Union Medical College Hospital West China Hospital of Sichuan University Chinese PLA General